Research Presentations

 
News Articles for Research Presentations top ^
Cutrale / Safra's Misleading Statements and Flawed Calculations Fail to Make the Case that their Contingent $13 Per Share Proposal is Adequate CHARLOTTE, N.C., Sept.
Sign-up for Chiquita Sends Letter to Shareholders and Files Investor Presentation to Set Record Straight on Proposed Combination With Fyffes investment picks
New Data from Ongoing Phase 1 AG-221 Trial Accepted for Oral Presentation CAMBRIDGE, Mass., Nov.
Sign-up for Agios Pharmaceuticals to Present Clinical and Preclinical Data at the 2014 American Society of Hematology Annual Meeting investment picks
On Wednesday, September 17, Xcel Energy’s (NYSE:XEL) Sr Vice President and CFO Teresa Madden will speak to the financial community at the Wolfe Research Power and Gas Leaders Conference in New York as follows: Interested investors can access the live audio webcast and presentation materials at: http://www.xcelenergy.com Click on: Investors The presentation material will be archived on our website.
Sign-up for Xcel Energy to Participate in Panel Presentations at Wolfe Research Power & Gas Leaders Conference investment picks
On Tuesday, September 16, Teresa Madden, Sr Vice President and CFO at Xcel Energy (NYSE:XEL) will participate in panel presentations at the Bank of America Merrill Lynch Power and Gas Leaders Conference in Boston as follows: Interested investors can access the live audio webcast of the panel and presentation materials at: http://www.xcelenergy.com Click on: Investors For more information, contact: Paul Johnson, Vice President, Investor Relations 612-215-4535 News media inquiries call Xcel Energy media relations 612-215-5300 Xcel Energy Internet address: www.xcelenergy.com This information is not given in connection with any sale or offer for sale or offer to buy any security.
Sign-up for Xcel Energy to Participate in Panel Presentations at Bank of America Merrill Lynch Conference investment picks
Demandware ®, Inc. (NYSE: DWRE), the industry-leading provider of enterprise cloud commerce solutions, today announced that the company will present at the following conference: Deutsche Bank Technology Conference Tim Adams, Demandware Chief Financial Officer, will present on Wednesday, September 10 th at 10:20 a.m. PDT at The Cosmopolitan of Las Vegas, NV An audio webcast of the presentation will be available on Demandware’s investor relations website at http://investors.demandware.com .
Sign-up for Demandware to Present at Upcoming Investor Conference investment picks
Health Care REIT, Inc. (NYSE:HCN) today made available updated corporate presentation materials on the Investor Relations section of its website ( www.hcreit.com ). The presentation includes, among other information, financial results from the second quarter of 2014, which the company announced on Friday, August 1, 2014.
Sign-up for Health Care REIT, Inc. Releases Updated Corporate Presentation investment picks
2014/9/3
Company CEO to present at both the Rodman & Renshaw Global Investment Conference and Aegis Capital 2014 Healthcare and Technology Conference in September JERUSALEM , September 3, 2014 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) ( http://www.oramed.com ), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today the Company's CEO, Nadav Kidron will present at the following conferences in September 2014 : 2014 Rodman & Renshaw Global Investment Conference Date: Tuesday, September 9, 2014 Time: 10:00am Eastern Time Location: New York Palace Hotel, Holmes I Salon A webcast of the presentation can be viewed at http://wsw.com/webcast/rrshq24/ormp and will be archived for an additional 90 days.
Sign-up for Oramed to Present at Upcoming Conferences investment picks
2014/9/3
PLYMOUTH MEETING, Pa.
Sign-up for Inovio to Present at Upcoming Investor Conferences investment picks
bluebird bio, Inc. (Nasdaq: BLUE) announces that management will present at the Morgan Stanley Global Healthcare Conference on Wednesday, September 10, 2014 at 2.30 PM ( EDT) at the Grand Hyatt New York Hotel, New York, NY.
Sign-up for bluebird bio to Present at Morgan Stanley Global Health Care Conference investment picks
YuMe, Inc. (NYSE:YUME), a leading provider of digital video brand advertising solutions, today announced that senior management will present at the following upcoming investor conferences: The live and archived Webcasts of the conference presentations will be available on the “Events & Presentations” section of http://investors.yume.com .
Sign-up for YuMe to Present at Upcoming Investor Conferences investment picks
2014/8/25
Fan Index, presented by Degree®, is a new fan-driven weekly index that will measure social media activity of fans as they "DO: MORE" in support of their favorite teams MCLEAN, Va.
Sign-up for USA TODAY Sports Launches "College Football Fan Index" Presented by Degree® investment picks
Fyffes' "Illustrative Value" Nothing More than Attempt to Persuade Chiquita Shareholders to Believe in Mythical Pot of Gold at the End of the Rainbow NEW YORK , Sept.
Sign-up for Cutrale-Safra Responds to Fyffes Investor Presentation investment picks
2014/9/24
Dynex Capital, Inc. (NYSE:DX) announced today that it is scheduled to present at the JMP Securities Financial Services and Real Estate Conference on September 30, 2014 at the St.
Sign-up for Dynex Capital, Inc. to Present at the JMP Securities Financial Services and Real Estate Conference investment picks
Enanta Pharmaceuticals, Inc., (NASDAQ: ENTA) a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, today announced that 25 abstracts reporting the results of hepatitis C virus (HCV) treatment regimens containing ABT-450, Enanta’s lead protease inhibitor, or ABT-493, Enanta’s next-generation protease inhibitor, have been accepted for presentation at The Liver Meeting, the Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), being held November 7-11, 2014 in Boston, MA.
Sign-up for Enanta Pharmaceuticals Announces Data Presentations on Regimens Containing ABT-450 or ABT-493 to be Presented at the American Association for the Study of Liver Diseases (AASLD) investment picks
Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, today announced, in conjunction with its development partner Eisai, that clinical data from the ongoing Phase 1 study of EPZ-6438 (E7438), an oral, small molecule inhibitor of EZH2, will be featured in a late-breaking oral presentation at the 26 th EORTC-AACR-NCI Symposium on Molecular Targets and Cancer Therapeutics, to be held November 18-21 in Barcelona, Spain.
Sign-up for Epizyme Announces Clinical Data from Phase 1 Trial of EZH2 Inhibitor EPZ-6438 (E7438) to be Presented at EORTC-NCI-AACR Symposium investment picks
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a developer of innovative RNA-based therapeutics, today announced that it will give one oral presentation and two poster presentations on data from its ongoing Phase II and preclinical trials evaluating exon-skipping therapies for the treatment of Duchenne muscular dystrophy (DMD) at the International Congress of the World Muscle Society (WMS), being held from October 7-11, 2014, in Berlin, Germany.
Sign-up for Sarepta Therapeutics Announces Presentations at the 19th International Congress of the World Muscle Society investment picks
Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced the presentation of clinical and preclinical data in oral presentation and discussion sessions at the 12 th International Mesothelioma Interest Group (iMig) Conference being held October 22-24, 2014, at the Cape Town International Conference Centre in Cape Town, South Africa.
Sign-up for Verastem Presents New Data on Mesothelioma Programs at the 12th International Mesothelioma Interest Group Meeting investment picks
Health Care REIT, Inc. (NYSE:HCN) today made available updated corporate presentation materials on the Investor Relations section of its website ( www.hcreit.com ). The presentation includes, among other information, financial results from the third quarter of 2014, which the company announced on Tuesday, November 4, 2014.
Sign-up for Health Care REIT, Inc. Releases Updated Corporate Presentation investment picks
Blackbaud, Inc. (NASDAQ: BLKB ), a leading global provider of software and services for the nonprofit, charitable giving and education communities, today announced its senior executives will be giving a company presentation at two upcoming investor conferences: Presentations will be webcast live, available on-demand and archived for a limited time at www.blackbaud.com/investorrelations .
Sign-up for Blackbaud, Inc. Announces Company Presentation at Two Investor Conferences investment picks

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Research Presentations
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Research Practice  |  Next: Research Priorities